| Patent | Date |
|---|
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof
App 20220281947 - GILL; Saar ; et al. | 2022-09-08 |
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
Grant 11,407,805 - Gill , et al. August 9, 2 | 2022-08-09 |
Cd20 Therapies, Cd22 Therapies, And Combination Therapies With A Cd19 Chimeric Antigen Receptor (car)- Expressing Cell
App 20220195010 - Bitter; Hans ; et al. | 2022-06-23 |
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
Grant 11,359,002 - Gill , et al. June 14, 2 | 2022-06-14 |
Rna Engineered T Cells For The Treatment Of Cancer
App 20220170012 - June; Carl H. ; et al. | 2022-06-02 |
Altering Gene Expression in Modified T Cells and Uses Thereof
App 20220154190 - Zhao; Yangbing ; et al. | 2022-05-19 |
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
Grant 11,332,511 - Gill , et al. May 17, 2 | 2022-05-17 |
Altering Gene Expression in Modified T Cells and Uses Thereof
App 20220145306 - Zhao; Yangbing ; et al. | 2022-05-12 |
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
Grant 11,325,963 - Gill , et al. May 10, 2 | 2022-05-10 |
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
Grant 11,319,358 - Gill , et al. May 3, 2 | 2022-05-03 |
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
Grant 11,306,134 - Gill , et al. April 19, 2 | 2022-04-19 |
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
Grant 11,306,133 - Gill , et al. April 19, 2 | 2022-04-19 |
Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer
Grant 11,299,536 - Frigault , et al. April 12, 2 | 2022-04-12 |
Car-expressing Cells Against Multiple Tumor Antigens And Uses Thereof
App 20220089750 - June; Carl H. ; et al. | 2022-03-24 |
Toxicity management for anti-tumor activity of CARs
Grant 11,273,219 - June , et al. March 15, 2 | 2022-03-15 |
RNA engineered T cells for the treatment of cancer
Grant 11,274,298 - June , et al. March 15, 2 | 2022-03-15 |
Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias
App 20220073639 - RUELLA; Marco ; et al. | 2022-03-10 |
Treatment Of Cancer Using Humanized Anti-bcma Chimeric Antigen Receptor
App 20220064316 - Brogdon; Jennifer ; et al. | 2022-03-03 |
Compositions and Methods for Generating a Persisting Population of T Cells Useful for the Treatment of Cancer
App 20220056116 - Frigault; Matthew J. ; et al. | 2022-02-24 |
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof
App 20220041688 - GILL; Saar ; et al. | 2022-02-10 |
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof
App 20220033468 - GILL; Saar ; et al. | 2022-02-03 |
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof
App 20220033466 - GILL; Saar ; et al. | 2022-02-03 |
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof
App 20220033465 - GILL; Saar ; et al. | 2022-02-03 |
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof
App 20220033467 - GILL; Saar ; et al. | 2022-02-03 |
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof
App 20220002376 - GILL; Saar ; et al. | 2022-01-06 |
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof
App 20220002375 - GILL; Saar ; et al. | 2022-01-06 |
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof
App 20220002377 - GILL; Saar ; et al. | 2022-01-06 |
Altering gene expression in modified T cells and uses thereof
Grant 11,208,661 - Zhao , et al. December 28, 2 | 2021-12-28 |
Altering gene expression in modified T cells and uses thereof
Grant 11,203,758 - Zhao , et al. December 21, 2 | 2021-12-21 |
Use Of The Cd2 Signaling Domain In Second-generation Chimeric Antigen Receptors
App 20210371495 - June; Carl H. ; et al. | 2021-12-02 |
Tn-MUC1 Chimeric Antigen Receptor (CAR) T Cell Therapy
App 20210338733 - Posey; Avery D. ; et al. | 2021-11-04 |
Car-expressing cells against multiple tumor antigens and uses thereof
Grant 11,161,907 - June , et al. November 2, 2 | 2021-11-02 |
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
Grant 11,149,076 - Bitter , et al. October 19, 2 | 2021-10-19 |
Enhanced Antigen Presenting Ability Of Rna Car T Cells By Co-introduction Of Costimulatory Molecules
App 20210317183 - Zhao; Yangbing ; et al. | 2021-10-14 |
Treatment Of Cancer Using Humanized Anti-cd19 Chimeric Antigen Receptor
App 20210284752 - Brogdon; Jennifer ; et al. | 2021-09-16 |
Inducible Regulatory T-cell Generation For Hematopoietic Transplants
App 20210275650 - Riley; James L. ; et al. | 2021-09-09 |
Tn-MUC1 chimeric antigen receptor (CAR) T cell therapy
Grant 11,090,336 - Posey , et al. August 17, 2 | 2021-08-17 |
Methods For Improving The Efficacy And Expansion Of Immune Cells
App 20210246423 - Bedoya; Felipe ; et al. | 2021-08-12 |
Anti-BCMA chimeric antigen receptor
Grant 11,084,880 - Brogdon , et al. August 10, 2 | 2021-08-10 |
Use Of Inhibitory Chimeric Receptors To Prevent T Cell-induced Blood Brain Barrier Damage
App 20210230246 - Posey; Avery ; et al. | 2021-07-29 |
Therapeutic Regimens For Chimeric Antigen Receptor (car)- Expressing Cells
App 20210177896 - Porter; David L. ; et al. | 2021-06-17 |
Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
Grant 11,034,749 - Gill , et al. June 15, 2 | 2021-06-15 |
Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells
Grant 11,028,177 - Brogdon , et al. June 8, 2 | 2021-06-08 |
Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory molecules
Grant 11,028,143 - Zhao , et al. June 8, 2 | 2021-06-08 |
ICOS critically regulates the expansion and function of inflammatory human Th17 cells
Grant 11,001,805 - Riley , et al. May 11, 2 | 2021-05-11 |
Switch costimulatory receptors
Grant 10,981,969 - June , et al. April 20, 2 | 2021-04-20 |
Chimeric Antigen Receptor T Regulatory Cells for the Treatment of Atherosclerosis
App 20210060071 - POSEY; Avery D. ; et al. | 2021-03-04 |
Treatment of cancer using humanized anti-CD19 chimeric antigen receptor
Grant 10,927,184 - Brogdon , et al. February 23, 2 | 2021-02-23 |
Car T Cell Therapies With Enhanced Efficacy
App 20210047405 - Nobles; Christopher Loren ; et al. | 2021-02-18 |
Enhancing Activity of CAR T Cells by Co-Introducing a Bispecific Antibody
App 20210040234 - June; Carl H. ; et al. | 2021-02-11 |
Combination Therapy Using A Chimeric Antigen Receptor
App 20210038659 - June; Carl H. ; et al. | 2021-02-11 |
Use Of Icos-based Cars To Enhance Antitumor Activity And Car Persistence
App 20210009652 - June; Carl H. ; et al. | 2021-01-14 |
Compositions And Methods For T Cell Delivery Of Therapeutic Molecules
App 20210008188 - Zhao; Yangbing ; et al. | 2021-01-14 |
Altering Gene Expression in CART Cells and Uses Thereof
App 20200407728 - Zhao; Yangbing ; et al. | 2020-12-31 |
Human Mesothelin Chimeric Antigen Receptors And Uses Thereof
App 20200407460 - Beatty; Gregory ; et al. | 2020-12-31 |
Inducible regulatory t-cell generation for hematopoietic transplants
Grant 10,874,727 - Riley , et al. December 29, 2 | 2020-12-29 |
Chimeric Antigen Receptor Therapy In Combination With Il-15r And Il15
App 20200399383 - Scholler; John ; et al. | 2020-12-24 |
Targeting Cytotoxic Cells With Chimeric Receptors For Adoptive Immunotherapy
App 20200377589 - Beatty; Gregory ; et al. | 2020-12-03 |
Immune-enhancing Rnas For Combination With Chimeric Antigen Receptor Therapy
App 20200368268 - Johnson; Lexus R. ; et al. | 2020-11-26 |
Methods Of Making Chimeric Antigen Receptor-expressing Cells
App 20200370012 - Fraietta; Joseph A. ; et al. | 2020-11-26 |
Bcma-targeting Chimeric Antigen Receptor, Cd19-targeting Chimeric Antigen Receptor, And Combination Therapies
App 20200360431 - Garfall; Alfred ; et al. | 2020-11-19 |
Compositions and methods for T cell delivery of therapeutic molecules
Grant 10,828,353 - Zhao , et al. November 10, 2 | 2020-11-10 |
Methods for improving the efficacy and expansion of immune cells
Grant 10,829,735 - Bedoya , et al. November 10, 2 | 2020-11-10 |
Methods For B Cell Preconditioning In Car Therapy
App 20200339651 - Brogdon; Jennifer ; et al. | 2020-10-29 |
Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer
Grant 10,800,840 - Frigault , et al. October 13, 2 | 2020-10-13 |
Tn-MUC1 Chimeric Antigen Receptor (CAR) T Cell Therapy
App 20200306304 - Posey; Avery D. ; et al. | 2020-10-01 |
Methods to Expand a T Regulatory Cell Master Cell Bank
App 20200263131 - Riley; James L. ; et al. | 2020-08-20 |
Modified Monocytes/macrophage Expressing Chimeric Antigen Receptors And Uses Thereof
App 20200247870 - Kind Code | 2020-08-06 |
Enhancing activity of CAR T cells by co-introducing a bispecific antibody
Grant 10,696,749 - June , et al. June 30, 2 | 2020-06-30 |
Human mesothelin chimeric antigen receptors and uses thereof
Grant 10,640,569 - Beatty , et al. | 2020-05-05 |
Toxicity management for anti-tumor activity of CARs
Grant 10,603,378 - June , et al. | 2020-03-31 |
Rna Engineered T Cells For The Treatment Of Cancer
App 20200087659 - June; Carl H. ; et al. | 2020-03-19 |
Compositions and Methods for Targeting Stromal Cells for the Treatment of Cancer
App 20200079874 - June; Carl H. ; et al. | 2020-03-12 |
Use of ICOS-based CARS to enhance antitumor activity and CAR persistence
Grant 10,577,407 - June , et al. | 2020-03-03 |
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
Grant 10,577,417 - Beatty , et al. | 2020-03-03 |
Treatment Of Cancer Using Anti-cd19 Chimeric Antigen Receptor
App 20190388471 - June; Carl H. ; et al. | 2019-12-26 |
Use of the CD2 signaling domain in second-generation chimeric antigen receptors
Grant 10,501,519 - June , et al. Dec | 2019-12-10 |
Compositions and Methods for Regulating CAR T Cells
App 20190367610 - June; Carl H. ; et al. | 2019-12-05 |
Use Of The Cd2 Signaling Domain In Second-generation Chimeric Antigen Receptors
App 20190352369 - June; Carl H. ; et al. | 2019-11-21 |
Switch Costimulatory Receptors
App 20190345219 - June; Carl H. ; et al. | 2019-11-14 |
Methods For Treating Chronic Lymphocytic Leukemia (cll)
App 20190336530 - June; Carl H. ; et al. | 2019-11-07 |
Treatment Of Cancer Using Humanized Anti-egfrviii Chimeric Antigen Receptor
App 20190330356 - Brogdon; Jennifer ; et al. | 2019-10-31 |
Cd20 Therapies, Cd22 Therapies, And Combination Therapies With A Cd19 Chimeric Antigen Receptor (car)- Expressing Cell
App 20190292238 - Bitter; Hans ; et al. | 2019-09-26 |
Methods Of Making Chimeric Antigen Receptor - Expressing Cells
App 20190292257 - Bedoya; Felipe ; et al. | 2019-09-26 |
RNA engineered T cells for the treatment of cancer
Grant 10,421,960 - June , et al. Sept | 2019-09-24 |
Treatment of cancer using anti-CD19 Chimeric Antigen Receptor
Grant 10,357,514 - June , et al. July 23, 2 | 2019-07-23 |
Compositions and methods for targeting stromal cells for the treatment of cancer
Grant 10,329,355 - June , et al. | 2019-06-25 |
Activation and Expansion of T-Cells Using an Engineered Multivalent Signaling Platform as a Research Tool
App 20190177692 - June; Carl H. ; et al. | 2019-06-13 |
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor
Grant 10,308,717 - Brogdon , et al. | 2019-06-04 |
Combination Therapies Of Chimeric Antigen Receptors And Pd-1 Inhibitors
App 20190151365 - Anak; Oezlem ; et al. | 2019-05-23 |
Treatment Of Cancer Using 5 Humanized Anti-bcma Chimeric Antigen Receptor
App 20190153061 - Brogdon; Jennifer ; et al. | 2019-05-23 |
Artificial antigen presenting cells and uses thereof
Grant 10,286,066 - Riley , et al. | 2019-05-14 |
Treatment Of Cancer Using Humanized Anti-cd19 Chimeric Antigen Receptor
App 20190135940 - Brogdon; Jennifer ; et al. | 2019-05-09 |
Use Of Trans-signaling Approach In Chimeric Antigen Receptors
App 20190125797 - Powell, JR.; Daniel J. ; et al. | 2019-05-02 |
Methods of making chimeric antigen receptor-expressing cells
Grant 10,273,300 - Bedoya , et al. | 2019-04-30 |
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
Grant 10,253,086 - Bitter , et al. | 2019-04-09 |
Compositions and Methods for Generating a Persisting Population of T Cells Useful for the Treatment of Cancer
App 20190085063 - Frigault; Matthew J. ; et al. | 2019-03-21 |
Treatment of cancer using humanized anti-CD19 chimeric antigen receptor
Grant 10,221,245 - Brogdon , et al. | 2019-03-05 |
Inducible Regulatory T-cell Generation For Hematopoietic Transplants
App 20190022199 - Riley; James L. ; et al. | 2019-01-24 |
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
Grant 10,174,095 - Brogdon , et al. J | 2019-01-08 |
Compositions and Methods for Generating a Persisting Population of T Cells Useful for the Treatment of Cancer
App 20180371068 - Frigault; Matthew J. ; et al. | 2018-12-27 |
ICOS Critically Regulates the Expansion and Function of Inflammatory Human Th17 Cells
App 20180371414 - Riley; James L. ; et al. | 2018-12-27 |
Methods For B Cell Preconditioning In Car Therapy
App 20180334490 - Brogdon; Jennifer ; et al. | 2018-11-22 |
Use of a trans-signaling approach in chimeric antigen receptors
Grant 10,117,896 - Powell, Jr. , et al. November 6, 2 | 2018-11-06 |
Altering Gene Expression in Modified T Cells and Uses Thereof
App 20180312848 - Zhao; Yangbing ; et al. | 2018-11-01 |
Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule
App 20180282693 - June; Carl H. ; et al. | 2018-10-04 |
Use Of Cart19 To Deplete Normal B Cells To Induce Tolerance
App 20180271907 - June; Carl H. ; et al. | 2018-09-27 |
Car T Cell Therapies With Enhanced Efficacy
App 20180258149 - Motz; Gregory ; et al. | 2018-09-13 |
Compositions and Methods for Treatment of Cancer
App 20180258391 - June; Carl H. ; et al. | 2018-09-13 |
Toxicity Management for Anti-Tumor Activity of CARs
App 20180256712 - June; Carl H. ; et al. | 2018-09-13 |
Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule
App 20180243341 - June; Carl H. ; et al. | 2018-08-30 |
Toxicity Management for Anti-Tumor Activity of CARs
App 20180243411 - June; Carl H. ; et al. | 2018-08-30 |
Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof
App 20180244748 - GILL; Saar ; et al. | 2018-08-30 |
Methods for treating chronic lymphocytic leukemia (CLL)
Grant 10,046,008 - June , et al. August 14, 2 | 2018-08-14 |
Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer
Grant 10,040,846 - Frigault , et al. August 7, 2 | 2018-08-07 |
ICOS critically regulates the expansion and function of inflammatory human Th17 cells
Grant 9,994,818 - Riley , et al. June 12, 2 | 2018-06-12 |
Combination Of Chimeric Antigen Receptor Therapy And Amino Pyrimidine Derivatives
App 20180140602 - Angst; Daniela ; et al. | 2018-05-24 |
Methods For Improving The Efficacy And Expansion Of Chimeric Antigen Receptor?expressing Cells
App 20180133296 - Barrett; David Maxwell ; et al. | 2018-05-17 |
Phosphoglycerate Kinase 1 (pgk) Promoters And Methods Of Use For Expressing Chimeric Antigen Receptor
App 20180118834 - Brogdon; Jennifer ; et al. | 2018-05-03 |
Enhancing Activity of CAR T Cells by Co-Introducing a Bispecific Antibody
App 20180057609 - June; Carl H. ; et al. | 2018-03-01 |
Car-expressing Cells Against Multiple Tumor Antigens And Uses Thereof
App 20180044424 - June; Carl H. ; et al. | 2018-02-15 |
Use Of The Cd2 Signaling Domain In Second-generation Chimeric Antigen Receptors
App 20180037625 - June; Carl H. ; et al. | 2018-02-08 |
Use Of Icos-based Cars To Enhance Antitumor Activity And Car Persistence
App 20170362295 - June; Carl H. ; et al. | 2017-12-21 |
Compositions And Methods For T Cell Delivery Of Therapeutic Molecules
App 20170360913 - ZHAO; Yangbing ; et al. | 2017-12-21 |
Altering Gene Expression in CART Cells and Uses Thereof
App 20170335331 - Zhao; Yangbing ; et al. | 2017-11-23 |
Novel Artificial Antigen Presenting Cells and Uses Thereof
App 20170319684 - Riley; James L. ; et al. | 2017-11-09 |
Altering Gene Expression in Modified T Cells and Uses Thereof
App 20170290858 - ZHAO; Yangbing ; et al. | 2017-10-12 |
Use of the CD2 signaling domain in second-generation chimeric antigen receptors
Grant 9,783,591 - June , et al. October 10, 2 | 2017-10-10 |
Compositions and Methods for Treatment of Cancer
App 20170283775 - June; Carl H. ; et al. | 2017-10-05 |
Enhancing activity of CAR T cells by co-introducing a bispecific antibody
Grant 9,765,156 - June , et al. September 19, 2 | 2017-09-19 |
Compositions And Methods Of Stimulating And Expanding T Cells
App 20170258836 - Zhao; Yangbing ; et al. | 2017-09-14 |
Targeting Cytotoxic Cells With Chimeric Receptors For Adoptive Immunotherapy
App 20170260268 - Beatty; Gregory ; et al. | 2017-09-14 |
Methods And Compositions For Modified T Cells
App 20170258835 - Zhao; Yangbing ; et al. | 2017-09-14 |
Subset-optimized Chimeric Antigen Receptor-containing T-cells
App 20170209492 - June; Carl H. ; et al. | 2017-07-27 |
Use of ICOS-based CARs to enhance antitumor activity and CAR persistence
Grant 9,714,278 - June , et al. July 25, 2 | 2017-07-25 |
Effective Targeting Of Primary Human Leukemia Using Anti-cd123 Chimeric Antigen Receptor Engineered T Cells
App 20170183415 - Brogdon; Jennifer ; et al. | 2017-06-29 |
Methods For Improving The Efficacy And Expansion Of Immune Cells
App 20170137783 - Bedoya; Felipe ; et al. | 2017-05-18 |
Methods for assessing the suitability of transduced T cells for administration
Grant 9,572,836 - June , et al. February 21, 2 | 2017-02-21 |
Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells
Grant 9,573,988 - Brogdon , et al. February 21, 2 | 2017-02-21 |
Artificial antigen presenting cells and uses thereof
Grant 9,555,105 - Riley , et al. January 31, 2 | 2017-01-31 |
TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN RECEPTOR
App 20170008963 - Brogdon; Jennifer ; et al. | 2017-01-12 |
Compositions and methods for treatment of cancer
Grant 9,540,445 - June , et al. January 10, 2 | 2017-01-10 |
Cd20 Therapies, Cd22 Therapies, And Combination Therapies With A Cd19 Chimeric Antigen Receptor (car)- Expressing Cell
App 20160362472 - Bitter; Hans ; et al. | 2016-12-15 |
Compositions and methods for treatment of cancer
Grant 9,518,123 - June , et al. December 13, 2 | 2016-12-13 |
Activation and Expansion of T-Cells Using an Engineered Multivalent Signaling Platform as a Research Tool
App 20160348072 - June; Carl H. ; et al. | 2016-12-01 |
Enhanced Antigen Presenting Ability Of Rna Car T Cells By Co-introduction Of Costimulatory Molecules
App 20160340406 - Zhao; Yangbing ; et al. | 2016-11-24 |
Use of chimeric antigen receptor-modified T-cells to treat cancer
Grant 9,499,629 - June , et al. November 22, 2 | 2016-11-22 |
Compositions and Methods for Targeting Stromal Cells for the Treatment of Cancer
App 20160326265 - June; Carl H. ; et al. | 2016-11-10 |
Compositions and methods for treatment of cancer
Grant 9,481,728 - June , et al. November 1, 2 | 2016-11-01 |
Human Mesothelin Chimeric Antigen Receptors And Uses Thereof
App 20160311917 - Beatty; Gregory ; et al. | 2016-10-27 |
Compositions and methods for treatment of cancer
Grant 9,464,140 - June , et al. October 11, 2 | 2016-10-11 |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
Grant 9,453,199 - June , et al. September 27, 2 | 2016-09-27 |
Epitope Spreading Associated with CAR T-Cells
App 20160235787 - June; Carl H. ; et al. | 2016-08-18 |
Compositions and Methods for Treatment of Cancer
App 20160208012 - June; Carl H. ; et al. | 2016-07-21 |
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor
Grant 9,394,368 - Brogdon , et al. July 19, 2 | 2016-07-19 |
Compositions and Methods for Treatment of Cancer
App 20160194404 - June; Carl H. ; et al. | 2016-07-07 |
Methods Of Making Chimeric Antigen Receptor -expressing Cells
App 20160185861 - Bedoya; Felipe ; et al. | 2016-06-30 |
Compositions and methods for targeting stromal cells for the treatment of cancer
Grant 9,365,641 - June , et al. June 14, 2 | 2016-06-14 |
Compositions and Methods for Treatment of Cancer
App 20160159907 - June; Carl H. ; et al. | 2016-06-09 |
Inducible Regulatory T-cell Generation For Hematopoietic Transplants
App 20160151471 - Riley; James L. ; et al. | 2016-06-02 |
Compositions and Methods for Treatment of Cancer
App 20160130355 - June; Carl H. ; et al. | 2016-05-12 |
Use of chimeric antigen receptor-modified T cells to treat cancer
Grant 9,328,156 - June , et al. May 3, 2 | 2016-05-03 |
Treatment Of Cancer Using Humanized Anti-bcma Chimeric Antigen Receptor
App 20160046724 - Brogdon; Jennifer ; et al. | 2016-02-18 |
Methods For Treating Chronic Lymphocytic Leukemia (cll)
App 20160000829 - June; Carl H. ; et al. | 2016-01-07 |
Inducible regulatory T-cell generation for hematopoietic transplants
Grant 9,228,172 - Riley , et al. January 5, 2 | 2016-01-05 |
ICOS Critically Regulates the Expansion and Function of Inflammatory Human Th17 Cells
App 20150342994 - Riley; James L. ; et al. | 2015-12-03 |
Enhancing Activity of CAR T Cells by Co-Introducing a Bispecific Antibody
App 20150322169 - June; Carl H. ; et al. | 2015-11-12 |
Method for treating chronic lymphocytic leukemia (CC)
Grant 9,161,971 - June , et al. October 20, 2 | 2015-10-20 |
Use Of Cart19 To Deplete Normal B Cells To Induce Tolerance
App 20150290244 - June; Carl H. ; et al. | 2015-10-15 |
Treatment Of Cancer Using Anti-cd19 Chimeric Antigen Receptor
App 20150283178 - June; Carl H. ; et al. | 2015-10-08 |
ICOS critically regulates the expansion and function of inflammatory human Th17 cells
Grant 9,133,436 - Riley , et al. September 15, 2 | 2015-09-15 |
Methods for treatment of cancer
Grant 9,101,584 - June , et al. August 11, 2 | 2015-08-11 |
Compositions for treatment of cancer
Grant 9,102,760 - June , et al. August 11, 2 | 2015-08-11 |
Compositions for treatment of cancer
Grant 9,102,761 - June , et al. August 11, 2 | 2015-08-11 |
Toxicity Management for Anti-Tumor Activity of CARs
App 20150202286 - June; Carl H. ; et al. | 2015-07-23 |
Methods for Assessing the Suitability of Transduced T Cells for Administration
App 20150190428 - June; Carl H. ; et al. | 2015-07-09 |
Compositions and Methods for Regulating CAR T Cells
App 20150140019 - June; Carl H. ; et al. | 2015-05-21 |
Methods for Treatment of Cancer
App 20150118202 - June; Carl H. ; et al. | 2015-04-30 |
Compositions for Treatment of Cancer
App 20150099299 - June; Carl H. ; et al. | 2015-04-09 |
Compositions for Treatment of Cancer
App 20150093822 - June; Carl H. ; et al. | 2015-04-02 |
Compositions for treatment of cancer
Grant 8,975,071 - June , et al. March 10, 2 | 2015-03-10 |
Compositions for Treatment of Cancer
App 20150050729 - June; Carl H. ; et al. | 2015-02-19 |
Compositions and Methods for Generating a Persisting Population of T Cells Useful for the Treatment of Cancer
App 20150024482 - Frigault; Matthew J. ; et al. | 2015-01-22 |
Use Of Icos-based Cars To Enhance Antitumor Activity And Car Persistence
App 20150017141 - June; Carl H. ; et al. | 2015-01-15 |
Methods for treatment of cancer
Grant 8,916,381 - June , et al. December 23, 2 | 2014-12-23 |
Use Of The Cd2 Signaling Domain In Second-generation Chimeric Antigen Receptors
App 20140370045 - June; Carl H. ; et al. | 2014-12-18 |
Methods for Treatment of Cancer
App 20140370017 - June; Carl H. ; et al. | 2014-12-18 |
Compositions for treatment of cancer
Grant 8,911,993 - June , et al. December 16, 2 | 2014-12-16 |
Methods for treatment of cancer
Grant 8,906,682 - June , et al. December 9, 2 | 2014-12-09 |
TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN RECEPTOR
App 20140322275 - Brogdon; Jennifer ; et al. | 2014-10-30 |
Effective Targeting Of Primary Human Leukemia Using Anti-cd123 Chimeric Antigen Receptor Engineered T Cells
App 20140322212 - Brogdon; Jennifer ; et al. | 2014-10-30 |
Treatment Of Cancer Using Humanized Anti-cd19 Chimeric Antigen Receptor
App 20140271635 - Brogdon; Jennifer ; et al. | 2014-09-18 |
Rna Engineered T Cells For The Treatment Of Cancer
App 20140227237 - June; Carl H. ; et al. | 2014-08-14 |
Switch Costimulatory Receptors
App 20140219975 - June; Carl H. ; et al. | 2014-08-07 |
Novel Artificial Antigen Presenting Cells and Uses Thereof
App 20140212446 - Riley; James L. ; et al. | 2014-07-31 |
Activation and Expansion of T-Cells Using an Engineered Multivalent Signaling Platform as a Research Tool
App 20140186947 - June; Carl H. ; et al. | 2014-07-03 |
Artificial antigen presenting cells and uses therefor
Grant 8,722,400 - Riley , et al. May 13, 2 | 2014-05-13 |
Use of Chimeric Antigen Receptor-Modified T Cells to Treat Cancer
App 20140106449 - June; Carl H. ; et al. | 2014-04-17 |
Compositions and Methods for Targeting Stromal Cells for the Treatment of Cancer
App 20140099340 - June; Carl H. ; et al. | 2014-04-10 |
Use of a Trans-Signaling Approach in Chimeric Antigen Receptors
App 20140099309 - Powell, JR.; Daniel J. ; et al. | 2014-04-10 |
Modulation of regulatory T cells by human IL-18
Grant 8,679,471 - Carroll , et al. March 25, 2 | 2014-03-25 |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
Grant 8,637,307 - June , et al. January 28, 2 | 2014-01-28 |
Methods for Treatment of Cancer
App 20130309258 - June; Carl H. ; et al. | 2013-11-21 |
Compositions for Treatment of Cancer
App 20130288368 - June; Carl H. ; et al. | 2013-10-31 |
Use of Chimeric Antigen Receptor-Modified T-Cells to Treat Cancer
App 20130287748 - June; Carl H. ; et al. | 2013-10-31 |
Methods to Expand a T Regulatory Cell Master Cell Bank
App 20130101567 - Riley; James L. ; et al. | 2013-04-25 |
Methods for treating progressive multifocal leukoencephalopathy (PML)
Grant 8,415,150 - June , et al. April 9, 2 | 2013-04-09 |
ICOS Critically Regulates the Expansion and Function of Inflammatory Human Th17 Cells
App 20130071409 - Riley; James L. ; et al. | 2013-03-21 |
Methods for Treating Progressive Multifocal Leukoencephalopathy (PML)
App 20120263693 - June; Carl H. ; et al. | 2012-10-18 |
Modulation Of Regulatory T Cells By Human Il-18
App 20120064033 - CARROLL; RICHARD G. ; et al. | 2012-03-15 |
Methods for Treating Progressive Multifocal Leukoencephalopathy (PML)
App 20120034249 - June; Carl H. ; et al. | 2012-02-09 |
Inducible Regulatory T-Cell Generation for Hematopoietic Transplants
App 20110268752 - Riley; James L. ; et al. | 2011-11-03 |
Novel Artificial Antigen Presenting Cells and Uses Therefor
App 20110262467 - Riley; James L. ; et al. | 2011-10-27 |
Methods for downregulating CCR5 in T cells with anti-CD3 antibodies and anti-CD28 antibodies
Grant 7,927,595 - June , et al. April 19, 2 | 2011-04-19 |
Artificial antigen presenting cells and uses therefor
Grant 7,754,482 - Riley , et al. July 13, 2 | 2010-07-13 |
Modulation of Regulatory T Cells by Human IL-18
App 20100061958 - Carroll; Richard G. ; et al. | 2010-03-11 |
Methods For Treating Hiv Infected Subjects
App 20090155836 - JUNE; Carl H. ; et al. | 2009-06-18 |
Methods for selectively enriching TH1 and TH2 cells
Grant 7,479,269 - June , et al. January 20, 2 | 2009-01-20 |
Methods of treating autoimmune disease via CTLA-4IG
App 20080305092 - Thompson; Craig B. ; et al. | 2008-12-11 |
Methods for treating HIV infected subjects
Grant 7,232,566 - June , et al. June 19, 2 | 2007-06-19 |
Methods for selectively stimulating proliferation of T cells
Grant 7,175,843 - June , et al. February 13, 2 | 2007-02-13 |
Methods for transfecting T cells
Grant 7,172,869 - June , et al. February 6, 2 | 2007-02-06 |
Methods for selectively stimulating proliferation of T cells
Grant 7,144,575 - June , et al. December 5, 2 | 2006-12-05 |
Methods for transfecting T cells
App 20060246587 - June; Carl H. ; et al. | 2006-11-02 |
Methods for modulating expression of an HIV-1 fusion cofactor
App 20060204500 - June; Carl H. ; et al. | 2006-09-14 |
Compositions comprising a first agent which provides a primary activation signal to T cells and a second agent which stimulates an accessory molecule on the surface of T cells
App 20060205069 - June; Carl H. ; et al. | 2006-09-14 |
Methods for modulating T cell survival by modulating bcl-XL protein level
App 20060199780 - June; Carl H. ; et al. | 2006-09-07 |
Methods for selectively stimulating proliferation of T cells
App 20060140919 - June; Carl H. ; et al. | 2006-06-29 |
Methods for transfecting T cells
Grant 7,067,318 - June , et al. June 27, 2 | 2006-06-27 |
Methods for treating HIV infected subjects
App 20060099177 - June; Carl H. ; et al. | 2006-05-11 |
Novel artificial antigen presenting cells and uses therefor
App 20060034810 - Riley; James L. ; et al. | 2006-02-16 |
Methods for treating HIV infected subjects
App 20060013832 - June; Carl H. ; et al. | 2006-01-19 |
Methods of treating HIV infected subjects
Grant 6,905,680 - June , et al. June 14, 2 | 2005-06-14 |
Methods for selectively stimulating proliferation of T cells
Grant 6,905,681 - June , et al. June 14, 2 | 2005-06-14 |
Methods for selectively stimulating proliferation of T cells
Grant 6,887,466 - June , et al. May 3, 2 | 2005-05-03 |
Methods for transfecting T cells
App 20040203155 - June, Carl H. ; et al. | 2004-10-14 |
Methods of treating autoimmune disease via CTLA-4Ig
App 20040185046 - Thompson, Craig B. ; et al. | 2004-09-23 |
Methods for transfecting T cells
App 20040087025 - June, Carl H. ; et al. | 2004-05-06 |
Methods for modulating T cell responses by manipulating intracellular signal transduction
App 20040072766 - June, Carl H. | 2004-04-15 |
Methods for transfecting T cells
Grant 6,692,964 - June , et al. February 17, 2 | 2004-02-17 |
Methods of treating autoimmune disease via CTLA-4Ig
Grant 6,685,941 - Thompson , et al. February 3, 2 | 2004-02-03 |
Methods for selectively stimulating proliferation of T cells
App 20040001829 - June, Carl H. ; et al. | 2004-01-01 |
Methods for modulating T cell responses by manipulating intracellular signal transduction
Grant 6,632,789 - June October 14, 2 | 2003-10-14 |
Immunotherapy involving CD28 stimulation
App 20030157102 - Thompson, Craig B. ; et al. | 2003-08-21 |
Bioactive absorbable microparticles as therapeutic vaccines
App 20030124149 - Shalaby, Shalaby W. ; et al. | 2003-07-03 |
Methods For Selectively Stimulating Proliferation Of T Cells
App 20030099643 - JUNE, CARL H. ; et al. | 2003-05-29 |
Methods for selectively stimulating proliferation of T cells
Grant 6,534,055 - June , et al. March 18, 2 | 2003-03-18 |
Methods For Selectively Stimulating Proliferation Of T Cells
App 20020115214 - JUNE, CARL H. ; et al. | 2002-08-22 |
Method For Selectively Stimulating Proliferation Of T Cells
App 20020076407 - JUNE, CARL H. ; et al. | 2002-06-20 |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
Grant 6,352,694 - June , et al. March 5, 2 | 2002-03-05 |
Immunotherapy Involving Cd28 Stimulation
App 20010053361 - THOMPSON, CRAIG B. ; et al. | 2001-12-20 |
Methods for modulating T cell survival by modulating bcl-X.sub.L protein level
Grant 6,143,291 - June , et al. November 7, 2 | 2000-11-07 |
Murine hybridoma and antibody binding to CD28 receptor secreted by the hybridoma and method of using the antibody
Grant 5,948,893 - June , et al. September 7, 1 | 1999-09-07 |
Methods for selectively stimulating proliferation of T cells
Grant 5,858,358 - June , et al. January 12, 1 | 1999-01-12 |
Transgenic animal model for autoimmune diseases
Grant 5,718,883 - Harlan , et al. February 17, 1 | 1998-02-17 |
| 